Anatara Lifesciences Ltd News

Anatara Lifesciences Ltd: Anatara's GaRP granted EU patent

Sep 20 09:41

Anatara Lifesciences Ltd: Anatara Annual General Meeting & Director Nominations

Sep 10 17:20

Anatara Lifesciences Ltd: GaRP Irritable Bowel Syndrome Clinical Trial Update

Aug 30 06:12

Anatara Lifesciences Ltd: $626,000 received in R&D Tax Incentive for FY24

Aug 29 06:08

Anatara Lifesciences Ltd: Appendix 4C & Q4 FY24 Activities Report

Jul 30 10:40

Anatara Lifesciences Ltd: Change of Director's Interest Notice

Jul 12 06:49

Anatara Lifesciences Ltd: IBS Clinical Trial Stage 2 recruitment is proceeding well

Jun 13 07:00

Anatara Lifesciences Ltd: Quarterly Activities/Appendix 4C Cash Flow Report

Apr 30 08:08

Anatara Lifesciences Ltd: Trading Halt

Apr 29 06:40

Anatara Lifesciences Ltd: Recruitment 5 sites for Pivotal IBS Clinical Trial Stage 2

Apr 9 07:56

Anatara Lifesciences Ltd: Recruitment for Pivotal Phase II IBS Clinical Trial Stage 2

Feb 29 08:58

Anatara Lifesciences Ltd: Appendix 4C & Q2 FY24 Activities Report

Jan 24 06:36

Anatara Lifesciences Ltd: Change of Director's Interest Notice

Dec 13, 2023 06:00

Anatara Lifesciences Ltd: Change of Director's Interest Notice

Dec 12, 2023 07:00

Anatara Lifesciences Ltd: Change of Director's Interest Notice

Dec 11, 2023 06:15

Anatara Lifesciences Ltd: Change of Director's Interest Notice

Dec 11, 2023 06:14

Anatara Lifesciences Ltd: Trading Halt

Nov 1, 2023 06:34

Anatara Lifesciences Ltd: Appendix 4C & Q1 FY24 Activities Report

Oct 31, 2023 14:07

Anatara Lifesciences Ltd: IBS Trial Results Webinar and QA

Oct 17, 2023 11:18

Anatara Lifesciences Ltd: Anatara IBS trial positive secondary endpoint data analysis

Oct 17, 2023 06:13